Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors

Human Immunology

Volumn 73, Issue 5, 2012, Pages 502-510

  Corallini, Alfredo ^a   Mazzoni, Elisa ^a   Taronna, Angelo ^a   Manfrini, Marco ^a   Carandina, Giovanni ^b   Guerra, Giovanni ^b   Guaschino, Roberto ^c   Vaniglia, Francesca ^c   Magnani, Corrado ^d   Casali, Ferruccio ^e   Dolcetti, Riccardo ^f   Palmonari, Caterina ^g   Rezza, Giovanni ^h   Martini, Fernanda ^a   Barbanti Brodano, Giuseppe ^a   Tognon, Mauro G ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Clinical Laboratory Analysis   (Italy)

^c C Arrigo Children's Hospital   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^e City Hospital   (Italy)

^f Division of Experimental Oncology 2   (Italy)

^g Clinical Laboratory Analysis   (Italy)

^h ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Donor; ELISA; Epitope; Mimotope; Serum; SV40

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PROTEIN VP1; PROTEIN VP2; PROTEIN VP3; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION TEST; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SERUM; SIMIAN VIRUS 40; VIRUS CAPSID; VIRUS DETECTION; VIRUS NEUTRALIZATION;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BASE SEQUENCE; BLOOD DONORS; CAPSID PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MIDDLE AGED; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PHYLOGENY; POLYOMAVIRUS; SIMIAN VIRUS 40;

EID: 84860243167     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.02.009     Document Type: Article

References (47)

1. Barbanti-Brodano G., Martini F., De Mattei M., Lazzarin L., Corallini A., Tognon M. BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors. Adv Virus Res 1998, 50:69-99.
2. Martini F., Corallini A., Balatti V., Sabbioni S., Pancaldi C., Tognon M. Simian virus 40 in humans. Infect Agents Cancer 2007, 2:13.
3. Barbanti-Brodano G., Sabbioni S., Martini F., Negrini M., Corallini A., Tognon M. BK virus, JC virus and simian virus 40 infection in humans, and association with human tumors. Adv Exp Med Biol 2006, 577:319-341.
4. Barbanti-Brodano G., Sabbioni S., Martini F., Negrini M., Corallini A., Tognon M. Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology 2004, 318:1-9.
5. Pancaldi C., Balatti V., Guaschino R., Vaniglia F., Corallini A., Martini F., et al. Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution. J Infect 2009, 58:53-60.
6. Martini F., Dolcetti R., Gloghini A., Iaccheri L., Carbone A., Boiocchi M., et al. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int J Cancer 1998, 78:669-674.
7. Dolcetti R., Martini F., Quaia M., Gloghini A., Vignocchi B., Cariati R., et al. Simian virus 40 sequences in human lymphoblastoid B-cell lines. J Virol 2003, 77:1595-1597.
8. Martini F., Iaccheri L., Lazzarin L., Carinci P., Corallini A., Gerosa M., et al. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 1996, 56:4820-4825.
9. Martini F., Lazzarin L., Iaccheri L., Vignocchi B., Finocchiaro G., Magnani I., et al. Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer 2002, 94:1037-1048.
10. Vanchiere J.A., Abudayyeh S., Copeland C.M., Lu L.B., Graham D.Y., Butel J.S. Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol 2009, 47:2388-2391.
11. Jafar S., Rodriguez-Barradas M., Graham D.Y., Butel J.S. Serological evidence of SV40 infections in HIV-infected and HIV-negative adults. J Med Virol 1998, 54:276-284.
12. Butel J.S., Arrington A.S., Wong C., Lednicky J.A., Finegold M.J. Molecular evidence of simian virus 40 infections in children. J Infect Dis 1999, 180:884-887.
13. Butel J.S., Jafar S., Wong C., Arrington A.S., Opekun A.R., Finegold M.J., et al. Evidence of SV40 infections in hospitalized children. Hum Pathol 1999, 30:1496-1502.
14. Li R.M., Branton M.H., Tanawattanacharoen S., Falk R.A., Jennette J.C., Kopp J.B. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002, 13:2320-2330.
15. Li R.M., Mannon R.B., Kleiner D., Tsokos M., Bynum M., Kirk A.D., et al. BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation 2002, 74:1497-1504.
16. Vanchiere J.A., White Z.S., Butel J.S. Detection of BK virus and simian virus 40 in the urine of healthy children. J Med Virol 2005, 75:447-454.
17. Patel N.C., Vilchez R.A., Killen D.E., Zanwar P., Sroller V., Eldin K.W., et al. Detection of polyomavirus SV40 in tonsils from immunocompetent children. J Clin Virol 2008, 43:66-72.
18. Comar M., Zanotta N., Bovenzi M., Campello C. JCV/BKV and SV40 viral load in lymphoid tissues of young immunocompetent children from an area of north-east Italy. J Med Virol 2010, 82:1236-1240.
19. Stratton K., Almario D.A., McCormick M.C. SV40 contamination of polio vaccine and cancer. Institute of Medicine of the National Academies 2002, National Academies Press, Washington, DC.
20. Barbanti-Brodano G., Corallini A., Accolla R.S., Martini F., Re T.M. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 2004, 96:803-804. [author reply:804-5].
21. Carter J.J., Madeleine M.M., Wipf G.C., Garcea R.L., Pipkin P.A., Minor P.D., et al. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 2003, 95:1522-1530.
22. Viscidi R.P., Rollison D.E., Viscidi E., Clayman B., Rubalcaba E., Daniel R., et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003, 10:278-285.
23. Lundstig A., Eliasson L., Lehtinen M., Sasnauskas K., Koskela P., Dillner J. Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles. J Gen Virol 2005, 86:1703-1708.
24. Ribeiro T., Fleury M.J., Granieri E., Castellazzi M., Martini F., Mazzoni E., et al. Investigation of the prevalence of antibodies against neurotropic polyomaviruses BK, JC and SV40 in sera from patients affected by multiple sclerosis. Neurol Sci 2010, 31:517-521.
25. Nurgalieva Z.Z., Wong C., Zhangabylov A.K., Omarbekova Z.E., Graham D.Y., Vilchez R.A., et al. Polyomavirus SV40 infections in Kazakhstan. J Infect 2005, 50:142-148.
26. Kean J.M., Rao S., Wang M., Garcea R.L. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009, 5:e1000363.
27. Cattozzo E.M., Stocker B.A., Radaelli A., De Giuli Morghen C., Tognon M. Expression and immunogenicity of V3 loop epitopes of HIV-1, isolates SC and WMJ2, inserted in Salmonella flagellin. J Biotechnol 1997, 56:191-203.
28. El-Attar L.M., Partidos C.D., Howard C.R. A peptide mimotope of hepatitis C virus E2 protein is immunogenic in mice and block human anti-HCV sera. J Med Virol 2010, 82:1655-1665.
29. Guerrini R., Salvadori S., Rizzi A., Regoli D., Calo G. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor. Med Res Rev 2010, 30:751-777.
30. Wang H.T., Chang J.W., Guo Z., Li B.G. In silico-initiated cloning and molecular characterization of cortexin 3, a novel human gene specifically expressed in the kidney and brain, and well conserved in vertebrates. Int J Mol Med 2007, 20:501-510.
31. Jones D.T. Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 1999, 292:195-202.
32. Bryson K., McGuffin L.J., Marsden R.L., Ward J.J., Sodhi J.S., Jones D.T. Protein structure prediction servers at University College London. Nucleic Acids Res 2005, 33:W36-W38.
33. Lundegaard C., Lund O., Kesmir C., Brunak S., Nielsen M. Modeling the adaptive immune system: predictions and simulations. Bioinformatics 2007, 23:3265-3275.
34. Petersen B., Petersen T.N., Andersen P., Nielsen M., Lundegaard C. A generic method for assignment of reliability scores applied to solvent accessibility predictions. BMC Struct Biol 2009, 9:51.
35. Berman H.M., Bhat T.N., Bourne P.E., Feng Z., Gilliland G., Weissig H., et al. The Protein Data Bank and the challenge of structural genomics. Nat Struct Biol 2000, 7(suppl):957-959.
36. Neu U., Woellner K., Gauglitz G., Stehle T. Structural basis of GM1 ganglioside recognition by simian virus 40. Proc Natl Acad Sci U S A 2008, 105:5219-5224.
37. Roy A., Kucukural A., Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 2010, 5:725-738.
38. Zhang Y. Fully automated protein structure prediction in CASP8. Proteins 2009, 77(suppl 9):100-113. I-TASSER.
39. Li G., Feng Y., Kariyawasam S., Tivendale K.A., Wannemuehler Y., Zhou F., et al. AatA is a novel autotransporter and virulence factor of avian pathogenic Escherichia coli. Infect Immun 2010, 78:898-906.
40. Gasteiger E., Gattiker A., Hoogland C., Ivanyi I., Appel R.D., Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 2003, 31:3784-3788.
41. Swetly P., Brodano G.B., Knowles B., Koprowski H. Response of simian virus 40-transformed cell lines and cell hybrids to superinfection with simian virus 40 and its deoxyribonucleic acid. J Virol 1969, 4:348-355.
42. Portolani M., Marzocchi A., Barbanti-Brodano G., La Placa M. Prevalence in Italy of antibodies to a new human papovavirus (BK virus). J Med Microbiol 1974, 7:543-546.
43. Maraldi N.M., Barbanti-Brodano G., Portolani M., La Placa M. Ultrastructural aspects of BK virus uptake and replication in human fibroblasts. J Gen Virol 1975, 27:71-80.
44. Major E.O., Miller A.E., Mourrain P., Traub R.G., de Widt E., Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci U S A 1985, 82:1257-1261.
45. Neel J.V., Major E.O., Awa A.A., Glover T., Burgess A., Traub R., et al. Hypothesis: "rogue cell"-type chromosomal damage in lymphocytes is associated with infection with the JC human polyoma virus and has implications for oncopenesis. Proc Natl Acad Sci U S A 1996, 93:2690-2695.
46. Melnick J.L., Stinebaugh S. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol Med 1962, 109:965-968.
47. Morris J.A., Johnson K.M., Aulisio C.G., Chanock R.M., Knight V. Clinical and serologic responses in volunteers given vacuolating virus (SV-40) by respiratory route. Proc Soc Exp Biol Med 1961, 108:56-59.